Drugs / DBV1605
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04492683 | Aug 2020 → Mar 2024 | — | DBV Technologies | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DBV1605 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04492683 ↗ |
| Modality | Diagnostic / imaging agent | “Ready-to-use atopy patch test for diagnostic use” NCT04492683 ↗ |
| Route | Topical | “One active patch and one control patch applied to subjects” NCT04492683 ↗ |